John G. Gums

4.5k total citations
141 papers, 2.6k citations indexed

About

John G. Gums is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, John G. Gums has authored 141 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Cardiology and Cardiovascular Medicine, 36 papers in Endocrinology, Diabetes and Metabolism and 25 papers in Molecular Biology. Recurrent topics in John G. Gums's work include Hormonal Regulation and Hypertension (28 papers), Blood Pressure and Hypertension Studies (26 papers) and Pharmacogenetics and Drug Metabolism (15 papers). John G. Gums is often cited by papers focused on Hormonal Regulation and Hypertension (28 papers), Blood Pressure and Hypertension Studies (26 papers) and Pharmacogenetics and Drug Metabolism (15 papers). John G. Gums collaborates with scholars based in United States, Italy and United Kingdom. John G. Gums's co-authors include Julie A. Johnson, Rhonda M. Cooper‐DeHoff, Stephen T. Turner, Andrew Y. Hwang, Yan Gong, Eric Boerwinkle, Arlene B. Chapman, Amber L. Beitelshees, Kent R. Bailey and Benjamin J Epstein and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

John G. Gums

140 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John G. Gums United States 28 842 587 504 419 270 141 2.6k
Mordechai Muszkat Israel 25 664 0.8× 433 0.7× 332 0.7× 550 1.3× 239 0.9× 105 2.4k
Peter H. Vlasses United States 28 741 0.9× 255 0.4× 486 1.0× 261 0.6× 138 0.5× 176 2.9k
Pietro Minuz Italy 38 1.2k 1.5× 560 1.0× 685 1.4× 175 0.4× 297 1.1× 168 4.4k
Jonatan D. Lindh Sweden 26 419 0.5× 556 0.9× 349 0.7× 1.3k 3.0× 120 0.4× 83 2.9k
Robert J. Straka United States 30 350 0.4× 437 0.7× 709 1.4× 324 0.8× 505 1.9× 109 2.6k
Christina L. Aquilante United States 26 248 0.3× 371 0.6× 349 0.7× 829 2.0× 225 0.8× 87 2.3k
Matthew Doogue New Zealand 25 328 0.4× 976 1.7× 757 1.5× 195 0.5× 371 1.4× 94 3.1k
Jérôme Biollaz Switzerland 41 1.7k 2.0× 714 1.2× 1.2k 2.4× 432 1.0× 488 1.8× 155 6.1k
Hilary Wynne United Kingdom 28 690 0.8× 551 0.9× 236 0.5× 1.5k 3.7× 335 1.2× 76 3.5k
Thomas D. Nolin United States 39 640 0.8× 284 0.5× 819 1.6× 664 1.6× 310 1.1× 135 4.3k

Countries citing papers authored by John G. Gums

Since Specialization
Citations

This map shows the geographic impact of John G. Gums's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Gums with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Gums more than expected).

Fields of papers citing papers by John G. Gums

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John G. Gums. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Gums. The network helps show where John G. Gums may publish in the future.

Co-authorship network of co-authors of John G. Gums

This figure shows the co-authorship network connecting the top 25 collaborators of John G. Gums. A scholar is included among the top collaborators of John G. Gums based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John G. Gums. John G. Gums is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McDonough, Caitrin W., Steven M. Smith, Yan Gong, et al.. (2024). Integrated metabolomics analysis reveals mechanistic insights into variability in blood pressure response to thiazide diuretics and beta blockers. Clinical and Translational Science. 17(5). e13816–e13816. 1 indexed citations
2.
Langaee, Taimour, Daqing Wang, Rolf Renne, et al.. (2024). Circulating microRNA Biomarkers of Thiazide Response in Hypertension. Journal of the American Heart Association. 13(4). e032433–e032433. 4 indexed citations
3.
McDonough, Caitrin W., Steven M. Smith, Yan Gong, et al.. (2022). Influence of Genetic West African Ancestry on Metabolomics among Hypertensive Patients. Metabolites. 12(9). 783–783. 6 indexed citations
4.
McDonough, Caitrin W., Steven M. Smith, Yan Gong, et al.. (2021). Metabolomics Signature of Plasma Renin Activity and Linkage with Blood Pressure Response to Beta Blockers and Thiazide Diuretics in Hypertensive European American Patients. Metabolites. 11(9). 645–645. 8 indexed citations
5.
Smith, Steven M., et al.. (2019). Erenumab: A First-in-Class Monoclonal Antibody for Migraine Prevention. Annals of Pharmacotherapy. 53(9). 933–939. 15 indexed citations
6.
Smith, Steven M., et al.. (2018). Betrixaban: A New Oral Factor Xa Inhibitor for Extended Venous Thromboembolism Prophylaxis in High-Risk Hospitalized Patients. Annals of Pharmacotherapy. 52(6). 554–561. 8 indexed citations
7.
Webb, Amy, Yan Gong, Caitrin W. McDonough, et al.. (2017). Whole Transcriptome Sequencing Analyses Reveal Molecular Markers of Blood Pressure Response to Thiazide Diuretics. Scientific Reports. 7(1). 16068–16068. 6 indexed citations
8.
Carris, Nicholas W., Andrew Y. Hwang, Steven M. Smith, et al.. (2016). Patient satisfaction with extended-interval warfarin monitoring. Journal of Thrombosis and Thrombolysis. 42(4). 486–493. 8 indexed citations
9.
Smith, Steven M., Xuerong Wen, Yan Gong, et al.. (2014). Baseline predictors of central aortic blood pressure: A PEAR substudy. Journal of the American Society of Hypertension. 8(3). 152–158. 9 indexed citations
10.
Hamadeh, Issam S., Taimour Langaee, R. Dwivedi, et al.. (2014). Impact of CYP2D6 Polymorphisms on Clinical Efficacy and Tolerability of Metoprolol Tartrate. Clinical Pharmacology & Therapeutics. 96(2). 175–181. 72 indexed citations
11.
McDonough, Caitrin W., Nancy Gillis, Abdullah Alsultan, et al.. (2013). Atenolol Induced HDL-C Change in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study. PLoS ONE. 8(10). e76984–e76984. 11 indexed citations
12.
Lobmeyer, Maximilian T., Jing Cheng, Zhiying Wang, et al.. (2013). Impact of Genetic Polymorphisms of SLC2A2, SLC2A5, and KHK on Metabolic Phenotypes in Hypertensive Individuals. PLoS ONE. 8(1). e52062–e52062. 12 indexed citations
13.
Turner, S. T., G. L. Schwartz, Arlene B. Chapman, et al.. (2010). Plasma Renin Activity Predicts Blood Pressure Responses to  -Blocker and Thiazide Diuretic as Monotherapy and Add-On Therapy for Hypertension. American Journal of Hypertension. 23(9). 1014–1022. 58 indexed citations
14.
Smith, Steven M. & John G. Gums. (2009). Fexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders. Expert Opinion on Drug Metabolism & Toxicology. 5(7). 813–822. 24 indexed citations
15.
Beitelshees, Amber L., Yan Gong, Kent R. Bailey, et al.. (2009). Comparison of Office, Ambulatory, and Home Blood Pressure Antihypertensive Response to Atenolol and Hydrochlorthiazide. Journal of Clinical Hypertension. 12(1). 14–21. 9 indexed citations
16.
17.
Gums, John G., et al.. (1999). A Randomized, Prospective Study Measuring Outcomes after Antibiotic Therapy Intervention by a Multidisciplinary Consult Team. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(12). 1369–1377. 100 indexed citations
18.
Gums, John G., et al.. (1996). Alpha blockers: a reassessment of their role in therapy.. PubMed. 54(1). 263–70. 3 indexed citations
19.
Gums, John G., et al.. (1995). Outcome Analysis of a Pharmacist‐Managed Anticoagulation Service. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 15(6). 732–739. 130 indexed citations
20.
Gums, John G., et al.. (1992). Treatment of Type I Diabetes with a Combination of Glyburide and Insulin. Annals of Pharmacotherapy. 26(6). 757–762. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mordechai Muszkat Breakdown of academic impact, for papers by Peter H. Vlasses Breakdown of academic impact, for papers by Pietro Minuz Breakdown of academic impact, for papers by Jonatan D. Lindh Breakdown of academic impact, for papers by Robert J. Straka Breakdown of academic impact, for papers by Christina L. Aquilante Breakdown of academic impact, for papers by Matthew Doogue Breakdown of academic impact, for papers by Jérôme Biollaz Breakdown of academic impact, for papers by Hilary Wynne Breakdown of academic impact, for papers by Thomas D. Nolin
Rankless by CCL
2026